Publications

(Displaying in Reverse Chronological Order)

  1. अनुसंधान
  2. Publications
  3. Publications
2296
Singh S, Mariappan TT and Bhutani H. Novel anti-TB FDC formulations without reduced bioavailability of rifampicin: from concept to market International Journal of Tuberculosis and Lung Disease 2005, 9, 701-702.
2297
Sobhia ME and Bharatam PV. Comparative molecular similarity indices analysis (CoMSIA) studies of 1,2-naphthoquinone derivatives as PTP1B inhibitors Bioorganic & Medicinal Chemistry 2005, 13, 2331-2338.
2298
Soni P and Banerjee UC. Biotransformations for the production of the chiral drug (S)-Duloxetine catalyzed by a novel isolate of Candida tropicalis Applied Microbiology and Biotechnology 2005, 67, 771-777.
2299
Soni P, Banerjee UC and Mariappan TT. High-performance liquid chromatographic method for the simultaneous estimation of the key intermediates of duloxetine Talanta 2005, 67, 975-978.
2300
Soni P, Banerjee UC, Kaur G and Chakraborti AK. Candida viswanathii as a novel biocatalyst for stereoselective reduction of heteroaryl methyl ketones: A highly efficient enantioselective synthesis of (S)-α-(3-pyridyl)ethanol Tetrahedron Asymmetry 2005, 16, 2425-2428.
2301
Sonkusare S, Srinivasan K, Kaul CL and Ramarao P. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats Life Sciences 2005, 77, 14-1.
2302
Srikanth CV, Chakraborti AK, Bachhawat AK. Acetaminophen Toxicity and Resistance in the Yeast Saccharomyces Cerevisiae Microbiology 2005, 151, 99-111.
2303
Srinivasan K, Kaul CL and Ramarao P. Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice [2] Indian Journal of Pharmacology 2005, 37, 327-328.
2304
Srinivasan K, Viswanad B, Asrat L, Kaul CL and Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharmacological Research 2005, 52, 313-320.
2305
Tamta H, Thilagavathi R, Chakraborti AK and Mukhopadhyay AK. 6-(N-benzoylamino)purine as a novel and potent inhibitor of xanthine oxidase: inhibition mechanism and molecular modeling studies Journal of Enzyme Inhibition and Medicinal Chemistry 2005, 20, 317-324.
2306
Thilagavathi R, Kumar R, Aparna V, Sobhia ME, Gopalakrishnan B and Chakraborti AK. Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA) Bioorganic & Medicinal Chemistry Letters 2005, 15, 1027-1032.
2307
Varma MV and Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo European Journal of Pharmaceutical Sciences 2005, 25, 445-453.
2308
Varma MV and Panchagnula R. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ Journal of Pharmaceutical Sciences 2005, 94, 2632-2643.
2309
Varma MV and Panchagnula R. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability Journal of Pharmaceutical Sciences 2005, 94, 1694-1704.
2310
Varma MV, Kaushal AM and Garg S. Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices Journal of Controlled Release 2005, 103, 499-510.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|154|15